We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




The COVID-19 Coronavirus Remains Viable for Hours or Days on Solid Surfaces

By LabMedica International staff writers
Posted on 30 Mar 2020
A recently published paper sheds light on how coronavirus spreads through the air and how long it remains viable on various solid surfaces.

A novel coronavirus of zoonotic origin, SARS-CoV-2 (2019-nCoV) was first identified in patients with acute respiratory disease (COVID-19). More...
This virus is genetically similar to SARS coronavirus and bat SARS-like coronaviruses. The outbreak was initially detected in Wuhan, a major city of China, but has subsequently exploded into a pandemic, which is raging in most of the countries of the world. At this time more than 425,000 cases of the disease have been confirmed with thousands of fatalities. Signs of infection are highly non-specific and these include respiratory symptoms, fever, cough, dyspnea, and viral pneumonia. The elderly and those with chronic diseases seem to suffer a more severe disease than does the younger, healthier population.

Many questions remain unanswered regarding how coronavirus spreads. To answer some of them, investigators at the University of California, Los Angeles (USA), the [U.S.] National Institute of Allergy and Infectious Diseases (Bethesda, MD, USA), the [U.S.] Centers for Disease Control and Prevention (Atlanta, GA, USA), and Princeton University (Princeton, NJ, USA) analyzed the aerosol and surface stability of SARS-CoV-2 and compared it with SARS-CoV-1, the most closely related human coronavirus.

For the study, aerosols similar to those observed in samples obtained from the upper and lower respiratory tract in humans, containing SARS-CoV-2 or SARS-CoV-1 were generated with the use of a three-jet Collison nebulizer. In addition, the viability of the viruses was determined in four environmental conditions (plastic, stainless steel, copper, and cardboard).

Results revealed that SARS-CoV-2 remained viable in aerosols throughout the duration of the three hour experiment, but with a small reduction in infectious titer. This reduction was similar to that observed with SARS-CoV-1.

SARS-CoV-2 was more stable on plastic and stainless steel than on copper and cardboard, and viable virus was detected up to 72 hours after application to these surfaces, although the virus titer was greatly reduced. Significant reduction in virus titers were noted after 72 hours on plastic, after 48 hours on stainless steel, 24 hours on cardboard, and only four hours on copper. The stability kinetics of SARS-CoV-1 were similar. This suggests that differences in the epidemiologic characteristics of these viruses probably arise from other factors, including high viral loads in the upper respiratory tract and the potential for persons infected with SARS-CoV-2 to shed and transmit the virus while asymptomatic.

While the results indicated that viable viruses could be detected for hours or days on some surfaces, it was not shown whether these viruses were still capable of causing the disease.

Contributing author Dr. James Lloyd-Smith, professor of ecology and evolutionary biology at the University of California, Los Angeles, said, "This virus is quite transmissible through relatively casual contact, making this pathogen very hard to contain. If you are touching items that someone else has recently handled, be aware they could be contaminated and wash your hands. The biology and epidemiology of the virus make infection extremely difficult to detect in its early stages because the majority of cases show no symptoms for five days or longer after exposure. Many people will not have developed symptoms yet."

The report appeared in the March 17, 2020, online edition of the journal New England Journal of Medicine.

Related Links:
University of California, Los Angeles
[U.S.] National Institute of Allergy and Infectious Diseases
Centers for Disease Control and Prevention
Princeton University



New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
Multichem ID-B
New
Automated PCR System
OnePCR
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.